NANada H. Almadhi

Nada H. Almadhi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nada H. Almadhi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exploring the intersection: adult orbital xanthogranulomatous disease and IgG4-related disease – report of 3 cases and literature review

    by Patrícia Barros da Silva, Ana Duarte, Nada H. Almadhi, Rand Alazzaz, Alexandra Borges, José Cabeçadas, Albertina Nunes, Dion Paridaens

    To examine the clinical, radiologic, and histopathologic overlap between adult orbital xanthogranulomatous disease (AOXD) and IgG4-related disease (IgG4-RD)/IgG4-related ophthalmic disease (IgG4-ROD), illustrated by three representative cases and a literature review. We retrospectively characterized three patients with AOXD, documenting presentation, imaging, histopathology, serum IgG4 levels, systemic associations, and treatment responses. A targeted narrative review appraised shared features, proposed diagnostic criteria, and evidence of overlap between AOXD and IgG4-ROD. We applied the 2019 ACR/EULAR classification criteria for IgG4-RD and ophthalmic criteria for IgG4-ROD. All three patients had progressive, painless periocular swelling with yellow-orange lesions and variable proptosis, consistent with AOXD subtypes. Imaging showed eyelid/anterior orbital and lacrimal gland/EOM involvement, patterns reported in AOXD and IgG4-RD. Histopathology showed xanthogranulomatous inflammation with foamy histiocytes/Touton giant cells; immunohistochemistry demonstrated increased, but variable, numbers of IgG4+ plasma cells; serum IgG4 ranged from normal to markedly elevated. Corticosteroids achieved partial responses, with relapses requiring steroid-sparing therapy or B-cell depletion (rituximab) in two cases. Literature synthesis suggests that IgG4-rich inflammation can accompany AOXD without fulfilling systemic IgG4-RD criteria; true coexistence of both conditions appears less common when modern criteria are applied. AOXD and IgG4-ROD share overlapping clinical, imaging, and histopathologic features. Comprehensive assessment - including serum IgG4, tissue IgG4+ plasma cell counts, and systemic organ involvement - is recommended to avoid misclassification. The role of IgG4 in AOXD remains unresolved; evolving criteria and mechanistic studies are needed to distinguish a true pathologic overlap from an epiphenomenon. Corticosteroids remain first-line, with selected cases benefitting from steroid-sparing agents.